|
|
|
|
|
|
|
Table 2. Time to an AIDS diagnosis after a diagnosis of HIV infection, by selected characteristics, 2004—33 states and U.S. dependent areas with confidential name-based HIV infection reporting
(Revised June 2007) |
|
|
|
|
|
|
|
|
|
|
|
|
|
≥12 Months after diagnosis of HIV infectiona |
|
<12 Months after diagnosis of HIV infectionb |
|
Total |
|
No. |
(%)c |
|
No. |
(%)c |
|
No. |
Data for 33 states |
|
|
|
|
|
|
|
Age at diagnosis (yrs) |
|
|
|
|
|
|
|
<13 |
149 |
84 |
|
29 |
16 |
|
179 |
13–14 |
28 |
79 |
|
7 |
21 |
|
35 |
15–19 |
838 |
83 |
|
172 |
17 |
|
1,010 |
20–24 |
2,707 |
78 |
|
777 |
22 |
|
3,484 |
25–29 |
2,914 |
69 |
|
1,291 |
31 |
|
4,204 |
30–34 |
3,232 |
64 |
|
1,787 |
36 |
|
5,019 |
35–39 |
3,561 |
59 |
|
2,463 |
41 |
|
6,024 |
40–44 |
3,173 |
56 |
|
2,482 |
44 |
|
5,655 |
45–49 |
2,062 |
51 |
|
1,994 |
49 |
|
4,056 |
50–54 |
1,233 |
49 |
|
1,262 |
51 |
|
2,495 |
55–59 |
654 |
46 |
|
760 |
54 |
|
1,414 |
60–64 |
330 |
45 |
|
404 |
55 |
|
735 |
>65 |
298 |
45 |
|
366 |
55 |
|
664 |
|
|
|
|
|
|
|
|
Race/ethnicity |
|
|
|
|
|
|
|
White, not Hispanic |
6,675 |
63 |
|
3,953 |
37 |
|
10,627 |
Black, not Hispanic |
10,485 |
60 |
|
6,890 |
40 |
|
17,375 |
Hispanic |
3,577 |
57 |
|
2,661 |
43 |
|
6,238 |
Asian/Pacific Islander |
194 |
56 |
|
155 |
44 |
|
350 |
American Indian/Alaska Native |
110 |
59 |
|
78 |
41 |
|
188 |
|
|
|
|
|
|
|
|
Transmission category |
|
|
|
|
|
|
|
Male adult or adolescent |
|
|
|
|
|
|
|
Male-to-male sexual contact |
10,305 |
63 |
|
6,147 |
37 |
|
16,452 |
Injection drug use |
1,663 |
50 |
|
1,671 |
50 |
|
3,334 |
Male-to-male sexual contact and injection drug use |
779 |
59 |
|
531 |
41 |
|
1,310 |
High-risk heterosexual contactd |
2,180 |
53 |
|
1,922 |
47 |
|
4,102 |
Othere |
59 |
47 |
|
66 |
53 |
|
125 |
Subtotal |
14,986 |
59 |
|
10,337 |
41 |
|
25,323 |
|
|
|
|
|
|
|
|
Female adult or adolescent |
|
|
|
|
|
|
|
Injection drug use |
1,157 |
60 |
|
782 |
40 |
|
1,939 |
High-risk heterosexual contactd |
4,829 |
65 |
|
2,577 |
35 |
|
7,405 |
Othere |
57 |
46 |
|
68 |
54 |
|
125 |
Subtotal |
6,043 |
64 |
|
3,427 |
36 |
|
9,470 |
|
|
|
|
|
|
|
|
Child (<13 yrs at diagnosis) |
|
|
|
|
|
|
|
Perinatal |
126 |
81 |
|
29 |
19 |
|
155 |
Otherf |
24 |
95 |
|
1 |
5 |
|
25 |
Subtotal |
149 |
83 |
|
30 |
17 |
|
180 |
|
|
|
|
|
|
|
|
Subtotal for 33 states |
21,178 |
61 |
|
13,795 |
39 |
|
34,973 |
|
|
|
|
|
|
|
|
Data for U.S. dependent areas |
21 |
52 |
|
19 |
48 |
|
41 |
Totalg |
21,200 |
61 |
|
13,814 |
39 |
|
35,014h |
|
|
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case counts. The reported case counts
have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor, but not for incomplete reporting.
|
See
Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least 2001. |
Data exclude 39 persons whose month of diagnosis of HIV infection is unknown. |
|
|
a |
Includes persons in whom AIDS has not developed |
b |
Includes persons whose diagnoses of HIV infection and AIDS were made at the same time. |
c |
Percentages represent proportions of the total number of diagnoses of HIV/AIDS made during 2004 for the corresponding group (see row entries). |
d |
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. |
e |
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified. |
f |
Includes hemophilia, blood transfusion, and risk factor not reported or not identified. |
g |
Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total. |
h |
Includes 194 persons of unknown race or multiple races. |
|
Next: Table 3 |
|
|
|
|
|
|
|
|